Avricore Health Inc. (TSXV: AVCR) is pleased to announce its audited results for 2023. The Company nearly doubled its previous record revenues to $3,485,147. Gross profit increased by 163% to $1,203,396. This integration will provide a more comprehensive health data tool for combating diabetes.